Brief: Wanbury Receives Sertraline Form II Approval From Anvisa, Brazil
12/03/2026 03:57
March 12 (Reuters) - Wanbury Ltd WANB.NS: RECEIVES SERTRALINE FORM II APPROVAL FROM ANVISA, BRAZIL RECEIVES APPROVAL FOR SPECIAL GRADE METFORMIN Source text: ID:nBSE3w4BB Further company coverage: WANB.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Wanbury
See all newsBrief: Wanbury Says Tanuku API Site Completes TGA Quality Inspection
Brief: Wanbury Expanded Regulatory Submission For New Active Pharmaceutical Ingredients
Brief: Wanbury Says Patalganga Site Has Completed Korea FDA Regulatory Inspection Successfully
Brief: Wanbury Ltd Launches Coriminic CPM Drops For Pediatric Use
Brief: Wanbury Receives Sertraline Form II Approval From Anvisa, Brazil